The first three generics introduced make the biggest dent on prices. But the vast majority of generic-drug approvals from 2012 to 2017 were for the fourth, fifth, sixth or even later versions that minimally impact prices, according to a new report.
Executives from seven major drugmakers, including Bristol-Myers Squibb Co., Merck & Co. and Pfizer are set to testify before the Senate Finance Committee on drug prices.
The Senate Finance Committee is demanding top insulin makers explain why prices for the lifesaving drug are so high.
Florida's Republican governor wants his state to become the first to import drugs from Canada, and he is asking his friend President Donald Trump for help.
The proposal marks another major milestone for the advanced cancer treatment and could be a windfall for hospitals.
Gilead Sciences is accused of giving kickbacks to healthcare organizations, government agencies, universities and community groups to boost sales of its hepatitis and HIV drugs, resulting in billions of dollars in excess government spending.
Alex Azar blasted the insurer practice of having a patient start over on step therapy if they switch insurance plans, as HHS aims to apply step therapy to Medicare Part B and D.
The latest and greatest health IT innovations will be on display among the nearly 1,200 vendors. Top level HHS officials, including Alex Azar, Seema Verma and Dr. Donald Rucker, are scheduled to speak.
The proposal led by Rep. Lloyd Doggett (D-Texas) and Sen. Sherrod Brown (D-Ohio) would let the government override patents if manufacturers don't play ball on drug prices for Part D.
House and Senate lawmakers reintroduced the Creates Act, a controversial bill aimed at curbing tactics brand-name drugmakers use to stymie generic and biosimilar competition.
Highmark Health CFO Karen Hanlon says the integrated delivery system is focused on expanding some of its value-based initiatives.
After HHS proposed eliminating the safe harbor protection for Medicare Part D drug rebates, Secretary Alex Azar suggested commercial plans will also get rid of the rebates in order to align with the market.